Try our free symptom checker
Get a thorough self-assessment before your visit to the doctor.
ADHD and hormones interact in ways that can make symptoms harder to handle, especially during hormonal shifts before your period. The sudden drop in estrogen and rise in progesterone disrupt neurotransmitters like dopamine, which is already lower in people with ADHD.
As a result, focus, mood, and energy levels can spiral, leaving you more irritable, forgetful, and emotionally drained.
🔑Key takeaways
- ADHD symptoms often worsen before a period due to hormonal shifts, especially the drop in estrogen and rise in progesterone, which disrupt dopamine levels.
- Low estrogen and high progesterone during the luteal phase lead to increased irritability, forgetfulness, impulsivity, and mood swings in women with ADHD.
- Studies show that drops in estradiol reduce attention, memory, and emotional stability, making PMS a particularly challenging time for managing ADHD.
- Women with ADHD are more likely to experience severe PMS or premenstrual dysphoric disorder (PMDD), with research showing higher rates of PMDD compared to women without ADHD.
- Adjusting ADHD medication dosages during the premenstrual week has improved focus, energy, and mood for some women with minimal side effects.
- Early findings suggest cycle-based medication strategies could help manage hormonal symptom spikes, but more research is needed for long-term safety and effectiveness.
Why do ADHD symptoms worsen before your period?
Many women with ADHD notice a significant change in their symptoms as their menstrual cycle progresses. The days leading up to a period can feel overwhelming, with increased struggles in focus, mood regulation, and energy levels. This is largely due to hormonal fluctuations, particularly the shifts in estrogen and progesterone, which directly affect neurotransmitters like dopamine that are already imbalanced in ADHD.
Hormonal fluctuations before menstruation
ADHD symptoms often worsen in the days leading up to a period due to hormonal fluctuations, especially the drop in estrogen and the rise in progesterone. The luteal phase, which occurs after ovulation, is marked by declining estrogen and increasing progesterone.
These shifts illustrate the close link between ADHD and hormones. They lower dopamine levels, intensifying ADHD symptoms such as irritability, forgetfulness, impulsivity, and emotional dysregulation. High progesterone levels can drastically reduce dopamine, making the week before menstruation particularly difficult for women with ADHD.
Role of estrogen and dopamine
A study confirmed that 97 women who have ADHD symptoms, including inattention and impulsivity, become worsening just before and at the start of menstruation. Their findings showed that drops in estradiol, the most potent form of estrogen, play a key role in reducing attention, memory, and mood stability. This hormonal dip not only disrupts dopamine production but also magnifies cognitive difficulties.
According to another study, the rapid decline in estrogen during the perimenstrual phase directly impacts executive function and trait control. This leads to increased inattention and emotional instability in women with ADHD. These effects are further compounded by the interaction of low estrogen with heightened negative emotions during this phase of the cycle.
This sensitivity to hormonal changes is like a "double whammy" for women with ADHD. In a study, adjusting ADHD medication dosage premenstrally improved symptoms for nine women, supporting the idea that hormonal fluctuations significantly impact ADHD severity.
🎊Fun fact
A study found a strong link between ADHD and PMDD, with 31.4% of women with ADHD showing PMDD symptoms compared to just 9.8% of women without ADHD. This further highlights how hormonal shifts before menstruation intensify mood changes, attention problems, and other ADHD-related difficulties.
How does hormone sensitivity affect ADHD and PMS?
Hormone sensitivity plays a crucial role in how ADHD symptoms interact with PMS, often making symptoms more severe and harder to manage.
According to a study, women with ADHD have a higher likelihood of experiencing PMDD. Their study found that the prevalence of provisional PMDD among women with clinically diagnosed ADHD was 31.4%, while it was 41.1% among those with ADHD identified by symptom criteria, compared to only 9.8% in women without ADHD. These findings suggest that hormonal sensitivity, particularly to ovarian hormone changes, intensifies mood and cognitive symptoms in women with ADHD, making them more vulnerable to PMS-related difficulties.
Hormonal fluctuations directly affect neurotransmitters that are already dysregulated in ADHD. According to a study, a decrease in estradiol, especially when paired with increased progesterone or testosterone, is linked to higher ADHD symptom severity the following day, particularly in women with high impulsivity traits. Their research highlights that ADHD symptoms often peak during the early follicular and early luteal phases, when hormonal shifts are most pronounced. This interplay between low estrogen and rising progesterone can reduce dopamine availability, a neurotransmitter crucial for attention and impulse control.
✂️In sum
Hormonal sensitivity amplifies ADHD symptoms during PMS by influencing dopamine and other neurotransmitter systems. These underline the importance of considering hormonal phases when managing ADHD symptoms in women.
Can adjusting ADHD medications help during PMS?
Adjusting ADHD medications during PMS may help improve symptoms, as emerging research highlights the benefits of cycle-specific dosing strategies. Women with ADHD often report worsening symptoms during the luteal phase of their menstrual cycle. A study examined nine women with ADHD and comorbid conditions like PMDD. The researchers increased the stimulant dosage during the premenstrual week while closely monitoring outcomes. All participants experienced improved focus, energy, and mood with minimal side effects. These positive results encouraged all nine women to continue with the elevated premenstrual pharmacotherapy.
Low estrogen levels in the luteal phase can reduce dopamine activity, further impairing focus and emotional control. This hormonal drop weakens the effectiveness of regular ADHD medication. By slightly increasing the stimulant dose during this period, women were able to achieve symptom control similar to non-premenstrual weeks. This finding is significant because conventional dosing often fails to address the sharp symptom spikes linked to hormonal fluctuations.
According to another study, the interaction between psychostimulants and female sex hormones has not been fully investigated. Only a few studies have tailored ADHD treatment to the menstrual cycle, leaving a clear research gap. Despite this, clinical observations consistently show that medication efficacy declines during the luteal phase. This reinforces the need to individualize treatment plans, particularly for women with severe PMS or PMDD symptoms.
A survey of nearly 2,000 women with ADHD revealed that two-thirds experienced intense PMS or PMDD symptoms that interfered with daily functioning. The most reported issues included:
- Irritability (80%)
- Mood swings (79%)
- Difficulty concentrating (66%)
Many participants noted that their ADHD medications felt less effective in the week before menstruation. These experiences align with other findings that premenstrual dose adjustments can significantly ease cognitive and emotional challenges.
While early evidence supports the benefits of cycle dosing, it is stressed that longitudinal studies are necessary to determine the long-term safety and efficacy of this approach. Nonetheless, it is suggested that carefully increasing stimulant medication during PMS could be a practical solution for many women with ADHD who struggle with hormonal symptom flare-ups.
Wrap Up
Hormonal fluctuations before menstruation intensify ADHD and hormones interactions, making focus, mood, and energy control more difficult. The sharp drop in estrogen and rise in progesterone disrupt dopamine levels, worsening impulsivity, irritability, and cognitive performance. This explains why many women with ADHD experience severe PMS or even PMDD, with symptoms peaking during the luteal phase.
Research highlights that adjusting ADHD medication during this period can help stabilize mood and improve concentration, offering a targeted approach to symptom management. Understanding how ADHD and hormones interact allows for better planning, treatment adjustments, and strategies to manage these cyclical challenges effectively.
Frequently Asked Questions
Can tracking my menstrual cycle help with ADHD symptoms?
Absolutely. Tracking helps you see patterns and plan around tough days. You can schedule demanding tasks when symptoms are lighter and prepare coping strategies for PMS weeks.
How does the follicular phase affect ADHD symptoms?
During the follicular phase (after your period), estrogen rises, improving mood, focus, and productivity. Many feel like they can “get more done” during this time.
What lifestyle changes can reduce PMS-related ADHD symptoms?
Regular exercise, balanced nutrition, proper sleep, and stress management techniques like yoga or meditation can help. Planning ahead for PMS weeks also makes a big difference.
Was this article helpful?
References
- Harper, K. (2025, January 8). ADHD symptoms can fluctuate with the menstrual cycle. Scientific American. https://doi.org/10.1038/scientificamerican052025-78O77riRsrasSV1zbRNJvc
- Eng, A. G., Nirjar, U., Elkins, A. R., Sizemore, Y. J., Monticello, K. N., Petersen, M. K., Miller, S. A., Barone, J., Eisenlohr-Moul, T. A., & Martel, M. M. (2024). Attention-deficit/hyperactivity disorder and the menstrual cycle: Theory and evidence. Hormones and behavior, 158, 105466. https://doi.org/10.1016/j.yhbeh.2023.105466
- Broughton, T., Lambert, E., Wertz, J., & Agnew-Blais, J. (2025). Increased risk of provisional premenstrual dysphoric disorder (PMDD) among females with attention-deficit hyperactivity disorder (ADHD): Cross-sectional survey study. The British Journal of Psychiatry, 226(6), 410–417. https://doi.org/10.1192/bjp.2025.104
- Broughton, T., Lambert, E., Wertz, J., & Agnew-Blais, J. (2025). Increased risk of provisional premenstrual dysphoric disorder (PMDD) among females with attention-deficit hyperactivity disorder (ADHD): cross-sectional survey study. The British journal of psychiatry : the journal of mental science, 226(6), 410–417. https://doi.org/10.1192/bjp.2025.104
- Roberts, B., Eisenlohr-Moul, T., & Martel, M. M. (2018). Reproductive steroids and ADHD symptoms across the menstrual cycle. Psychoneuroendocrinology, 88, 105–114. https://doi.org/10.1016/j.psyneuen.2017.11.015
- de Jong, M., Wynchank, D. S. M. R., van Andel, E., Beekman, A. T. F., & Kooij, J. J. S. (2023). Female-specific pharmacotherapy in ADHD: premenstrual adjustment of psychostimulant dosage. Frontiers in psychiatry, 14, 1306194. https://doi.org/10.3389/fpsyt.2023.1306194
- Findeis, H., & Strauß, M. (2025). The effects of psychostimulants in menstruating women with ADHD – A gender health gap in ADHD treatment? Progress in Neuro-Psychopharmacology and Biological Psychiatry, 137, 111261. https://doi.org/10.1016/j.pnpbp.2025.111261